Managing Thrombotic Risk in Pregnancy: How the Lab May Help Perspective
World Thrombosis Day Webinar
Pregnancy changes how the body manages clotting risk, and understanding that shift starts in the lab. A free webinar, supported by Sysmex, examines thrombotic risk in pregnancy from three angles: diagnosis, treatment, and research.
Researchers and clinicians will discuss how thrombotic risk is assessed and managed before, during, and after pregnancy, and what current evidence means for patient care.
Preregister by October 6 for early access to this World Thrombosis Day webinar. The live premiere is October 12.
Why this webinar matters
Thrombotic risk in pregnancy does not stay constant. It shifts before conception, changes throughout pregnancy, and remains elevated for weeks after delivery. Managing that risk takes more than clinical judgment. It takes strong laboratory support, and that is what this webinar examines.
Who should attend
This webinar is designed for thrombosis professionals, OB-GYNs, lab technicians and researchers who want a practical, lab-informed view of thrombotic risk management in pregnancy. Whether you diagnose, treat or study thrombotic risk, this session offers perspective you can apply directly to patient care and research.
Don’t wait to save your spot. Register today.
What you will learn
In this 45-minute session, three experts examine how laboratory support guides care across the reproductive journey, from conception through pregnancy and beyond:
- How thrombotic risk shifts before conception, throughout pregnancy and postpartum
- How lab testing supports early diagnosis of thrombotic risk
- How lab results shape treatment and anticoagulation decisions during pregnancy
- What emerging research is changing how thrombotic risk in pregnancy is understood
Meet the speakers:
- Andreas Rechner, Ph.D., presenter, diagnostic perspective
Andreas Rechner, Ph.D., specializes in laboratory diagnostics and thrombotic risk assessment. He will present on how lab testing helps identify and monitor thrombotic risk before, during, and after pregnancy.
- Jim Douketis, M.D., treatment perspective
Jim Douketis, M.D., chairs the World Thrombosis Day campaign and is an expert in thrombosis treatment and anticoagulation management. He will discuss how lab support informs treatment decisions for thrombotic risk in pregnancy.
- Prof. Beverley Hunt, O.B.E. – research perspective
Prof. Beverley Hunt, O.B.E. is a professor of thrombosis and haemostasis at King’s College London and a founding member of the World Thrombosis Day steering committee. She will discuss how clinical evidence shapes the diagnosis and management of thrombotic risk throughout pregnancy.
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Sep 20, 2026, 12:44Justin Houman: Honored to Be Selected for Inclusion in 2027 Southern California Super Doctors Rising Stars
-
Sep 20, 2026, 12:41Lorene Lteif: Honored to Have Been a Speaker at the 2nd Trust Fertility and Gynecology Conference 2026
-
Sep 20, 2026, 12:39Maria Satchi: Presenting 2 Topics at BFS Study Week on Male Fertility
-
Sep 20, 2026, 12:36The Most Important Name Tag in Your IVF Journey – Indira IVF Group
-
Sep 20, 2026, 12:34Andris Ābele: Privileged to Participate in the 14th European Congress of Andrology
-
Sep 20, 2026, 12:31Ghyass Jutt: Can You Identify a Euploid Blastocyst Under the Inverted Microscope?
-
Sep 20, 2026, 12:29The FIGO 2027 Submission Platform Is Open
-
Sep 20, 2026, 11:20Beyond the Progesterone Number: Rethinking Embryo-Endometrial Synchrony in Frozen Embryo Transfer
-
Sep 20, 2026, 09:49Tommaso Simoncini: Support Not Stigma – 8th World Gynecologic Oncology Day